Gyeonggi-do Clinical Site

Gyeonggi-do 13620

0 studies enrolling now · 1 studies all time

What they study most

Esophageal Cancer

Studies at this site

• Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer — Completed